Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: M. Ramle who wrote (3348)	6/25/1999 10:34:00 AM
From: Biomaven	Read Replies (1) of 10280

From www.labpuppy.com on the SGP analyst meeting: They will file a NDA for desloratadine by year end. This is the Sepracor (SEPR) product that uses the active metabolite of Claritin. They hope to use this to extend the patent life on Claritin. They have a number of patents that they hope to user to defend Claritin for generic competition. Patent expirations; composition of matter – 2002, pediatric version – 2003, active metabolite – 2004, process – 2008 and Sepracor product – 2014. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next